Superior Group's Q2 Was Fine-Now the Stock Has to Prove It's More Than a Nice Quarter

Superior's Q2 improved, but not enough to end the debate

Superior Group delivered $147.8 million of net sales in the second quarter, up from $144.0 million a year earlier, and adjusted EBITDA rose to $7.7 million from $6.1 million. That is a clean enough result: the core business produced more profit even with only modest top-line growth. Reported diluted EPS, however, fell to $0.08 from $0.10 because of a $2.0 million after-tax tradename impairment. So a perfectly good quarter now raises the bar.

The bull case is stability. The company confirms full-year Outlook and approved $0.14 per share quarterly dividend. The bear case is that sales only edged higher and headline EPS missed, so this was not an obvious turnaround breakout. The next few quarters matter because management had already indicated results should be back-half weighted.

Branded Products showed the strongest quality in the quarter

Branded Products stood out

Branded Products remains the clearest bright spot. Revenue rose 5% year over year to $91 million, and gross margin increased by 210 basis points. Management tied that improvement to a more favorable customer mix, which makes the progress easier to trust.

Healthcare Apparel grew, but profitability slipped

Healthcare Apparel also grew revenue, but not without trade-offs. The segment's revenue reached $29 million, up 5%, while gross margin fell 160 basis points to 35.6% as the mix shifted toward lower-margin customers. The segment also recorded a $2.6 million tradename impairment. For now, that looks more like a rough patch than a broken business, but it still deserves scrutiny.

Contact Centers may be stabilizing

Contact Centers was the weakest line item on the surface, with revenue down 8% year over year. But the segment still showed sequential growth from the fourth quarter, which suggests the decline may be easing even if the business is not fully turned around.

The real test is whether the back half starts to show up

Reported EPS was dulled by a noncash charge

The headline EPS comparison can be misleading. Superior recorded a $2.6 million tradename impairment in Healthcare Apparel, equal to $2.0 million after tax, which pulled reported diluted EPS down to $0.08 from $0.10 a year ago. The quarter looks healthier once you separate that accounting charge from operating performance.

Management has already pointed investors to the second half

That timing is why the next few quarters matter. Management said 2026 results are expected to be back-half weighted, and another summary of the call said expectations are heavily weighted toward the second half for both revenue and EPS. If that starts to show up soon, investors are more likely to view Q2 as part of a larger improvement rather than a one-off steady quarter.

Where the bear case still has teeth

The risks have not gone away. Contact Centers still faced higher labor costs, and Healthcare Apparel was hurt by a shift toward lower-margin customers. Management has also pointed to pandemic-era supply chain and tariff disruptions as part of the backdrop Superior has learned to navigate. If those pressures intensify while the weaker segments are still stabilizing, the stock's case gets harder to defend.

For now, SGC still looks like a watchlist name with a sound enough quarter to keep attention on it. But the stock has to prove the second half can do more than match the first.